ASPE insider trading — Aspen Neuroscience, Inc.
Over the last 90 days, insiders at Aspen Neuroscience, Inc. (ASPE) made 3 open-market purchases worth $35.00M and 0 open-market sales worth $0, making them net buyers by $35.00M. The largest purchase was by Arch Venture Partners Xiv, L.P., Arch Venture Partners Xiv, Llc, Arch Venture Fund Xiv, L.P., Berns Paul L (10% Owner), who bought 1,200,000 shares for $18.00M on Nov 2, 2026. 3 different insiders bought shares in this period — a cluster buy, which many investors watch closely.
Updated Nov 5, 2026.
Recent ASPE insider transactions
Every Form 4 filed by Aspen Neuroscience, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Thompson Peter A. | Director | C · Conversion | Indirect | 2,589,132 | — | — | Form 4 |
| Nov 2, 2026 | Thompson Peter A. | Director | P · Purchase | Indirect | 1,000,000 | $15.00 | $15.00M | Form 4 |
| Nov 2, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Vii Llc | Director | C · Conversion | Indirect | 2,589,132 | — | — | Form 4 |
| Nov 2, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Vii Llc | Director | P · Purchase | Indirect | 1,000,000 | $15.00 | $15.00M | Form 4 |
| Nov 2, 2026 | Arch Venture Fund X, L.P., Arch Venture Fund X Overage, L.P., Arch Venture Partners X, L.P., Arch Venture Partners X Overage, L.P., Arch Venture Partners X, Llc, Crandell Keith, Burow Kristina, Gillis Steven, Nelsen Robert | 10% Owner | P · Purchase | Direct | 133,333 | $15.00 | $2.00M | Form 4 |
| Nov 2, 2026 | Arch Venture Fund X, L.P., Arch Venture Fund X Overage, L.P., Arch Venture Partners X, L.P., Arch Venture Partners X Overage, L.P., Arch Venture Partners X, Llc, Crandell Keith, Burow Kristina, Gillis Steven, Nelsen Robert | 10% Owner | C · Conversion | Direct | 2,421,589 | — | — | Form 4 |
| Nov 2, 2026 | Arch Venture Fund X, L.P., Arch Venture Fund X Overage, L.P., Arch Venture Partners X, L.P., Arch Venture Partners X Overage, L.P., Arch Venture Partners X, Llc, Crandell Keith, Burow Kristina, Gillis Steven, Nelsen Robert | 10% Owner | P · Purchase | Indirect | 1,200,000 | $15.00 | $18.00M | Form 4 |
| Nov 2, 2026 | Arch Venture Partners Xiv, L.P., Arch Venture Partners Xiv, Llc, Arch Venture Fund Xiv, L.P., Berns Paul L | 10% Owner | P · Purchase | Direct | 1,200,000 | $15.00 | $18.00M | Form 4 |
| Nov 2, 2026 | Spaventa Andrew | Director | C · Conversion | Indirect | 250,415 | — | — | Form 4 |
| Nov 2, 2026 | Hasnain Faheem | Executive Chair | C · Conversion | Indirect | 36,349 | — | — | Form 4 |
ASPE insider trading FAQ
Are insiders buying ASPE stock?
Yes. In the last 90 days, Aspen Neuroscience, Inc. insiders made 3 open-market purchases totaling $35.00M, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ASPE?
Recent buyers: Arch Venture Fund X, L.P., Arch Venture Fund X Overage, L.P., Arch Venture Partners X, L.P., Arch Venture Partners X Overage, L.P., Arch Venture Partners X, Llc, Crandell Keith, Burow Kristina, Gillis Steven, Nelsen Robert, Arch Venture Partners Xiv, L.P., Arch Venture Partners Xiv, Llc, Arch Venture Fund Xiv, L.P., Berns Paul L, Thompson Peter A..
Where does ASPE insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.